| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Amivantamab plus lazertinib versus osimertinib in first-line EGFR-mutant advanced non-small-cell lung cancer with biomarkers of high-risk disease: a secondary analysis from MARIPOSA
|
Felip, E.
|
|
|
35 |
9 |
p. 805-816
|
article
|
| 2 |
Circumventing human limits in precision oncology: AI-enhanced tailoring of post-operative treatment for pancreatic ductal adenocarcinoma
|
Casalino, S.
|
|
|
35 |
9 |
p. 760-761
|
article
|
| 3 |
Development and validation of AI-assisted transcriptomic signatures to personalize adjuvant chemotherapy in patients with pancreatic ductal adenocarcinoma
|
Fraunhoffer, N.
|
|
|
35 |
9 |
p. 780-791
|
article
|
| 4 |
Editorial Board
|
|
|
|
35 |
9 |
p. iii
|
article
|
| 5 |
Efficacy and safety of ramucirumab plus carboplatin and paclitaxel in untreated metastatic thymic carcinoma: RELEVENT phase II trial (NCT03921671)
|
Proto, C.
|
|
|
35 |
9 |
p. 817-826
|
article
|
| 6 |
ESMO Clinical Practice Guideline interim update on new targeted therapies in the first line and at relapse of chronic lymphocytic leukaemia ☆
|
Eichhorst, B.
|
|
|
35 |
9 |
p. 762-768
|
article
|
| 7 |
Impact of hormone receptor status and tumor subtypes of breast cancer in young BRCA carriers
|
Arecco, L.
|
|
|
35 |
9 |
p. 792-804
|
article
|
| 8 |
Primary tumor resection for asymptomatic colorectal cancer with unresectable metastasis: the end of the dilemma
|
Biondo, S.
|
|
|
35 |
9 |
p. 757-759
|
article
|
| 9 |
Reflections on the statistical methodology in nivolumab and ipilimumab therapy research
|
Yang, Sen
|
|
|
35 |
9 |
p. 827
|
article
|
| 10 |
Reply to the Letter to the Editor “Reflections on the statistical methodology in nivolumab and ipilimumab therapy research” by S. Yang
|
Melero, I.
|
|
|
35 |
9 |
p. 827-828
|
article
|
| 11 |
Reply to the Letter to the Editor regarding ‘Overcoming Barriers in Biomarker Testing’ J. García-Foncillas et al.
|
Bayle, A.
|
|
|
35 |
9 |
p. 829-830
|
article
|
| 12 |
Table of Contents
|
|
|
|
35 |
9 |
p. i-ii
|
article
|
| 13 |
Upfront resection versus no resection of the primary tumor in patients with synchronous metastatic colorectal cancer: the randomized phase III CAIRO4 study conducted by the Dutch Colorectal Cancer Group and the Danish Colorectal Cancer Group
|
van der Kruijssen, D.E.W.
|
|
|
35 |
9 |
p. 769-779
|
article
|
Journal description